anti-epidermal growth factor receptor 2 antibody expressing pluripotent killer T lymphocytes
Term · Oncology and biomedicine · MLC-T-ONC-010644
A specific population of pluripotent killer (PIK) T cells that have been induced to express high levels of antibodies against human epidermal growth factor receptor 2 (ERBB2; HER2), with potential antitumor activity. Although the exact mechanism(s) of action through which PIK-HER2 cells exert their effects has yet to be elucidated, upon infusion, these cells secrete antibodies targeting HER2 expressed on the surface of tumor cells. This may inhibit HER2-dependent signaling, which may lead to inhibition of cellular proliferation and differentiation. Additionally, these cells may stimulate the host immune system to mount both a highly-specific cytotoxic T-lymphocyte (CTL) response and antibody-dependent cell cytotoxicity (ADCC) directed against HER2-overexpressing tumors, which leads to tumor cell lysis. HER2 is a member of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases and is frequently overexpressed in solid tumors.
| Identifier | MLC-T-ONC-010644 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-epidermal growth factor receptor 2 antibody expressing pluripotent killer T cells; PIK-HER2; anti-ERBB2 antibody expressing pluripotent killer T lymphocytes; anti-HER2 antibody expressing pluripotent killer T lymphocytes; anti-ERBB2 antibody expressing pluripotent killer T cells; anti-HER2 antibody expressing pluripotent killer T cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010644",
"term": "anti-epidermal growth factor receptor 2 antibody expressing pluripotent killer T lymphocytes",
"field": "Oncology and biomedicine",
"definition": "A specific population of pluripotent killer (PIK) T cells that have been induced to express high levels of antibodies against human epidermal growth factor receptor 2 (ERBB2; HER2), with potential antitumor activity. Although the exact mechanism(s) of action through which PIK-HER2 cells exert their effects has yet to be elucidated, upon infusion, these cells secrete antibodies targeting HER2 expressed on the surface of tumor cells. This may inhibit HER2-dependent signaling, which may lead to inhibition of cellular proliferation and differentiation. Additionally, these cells may stimulate the host immune system to mount both a highly-specific cytotoxic T-lymphocyte (CTL) response and antibody-dependent cell cytotoxicity (ADCC) directed against HER2-overexpressing tumors, which leads to tumor cell lysis. HER2 is a member of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases and is frequently overexpressed in solid tumors.",
"synonyms": [
"anti-epidermal growth factor receptor 2 antibody expressing pluripotent killer T cells",
"PIK-HER2",
"anti-ERBB2 antibody expressing pluripotent killer T lymphocytes",
"anti-HER2 antibody expressing pluripotent killer T lymphocytes",
"anti-ERBB2 antibody expressing pluripotent killer T cells",
"anti-HER2 antibody expressing pluripotent killer T cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-epidermal-growth-factor-receptor-2-antibody-expressing-pluripotent-killer-t/"
}
Record 1,742 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.